Literature DB >> 8793791

Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus.

P M Deen1, R A van Aubel, A F van Lieburg, C H van Os.   

Abstract

Hereditary nephrogenic diabetes insipidus (NDI) is caused by mutations in either the X-chromosomal gene encoding the vasopressin V2-receptor or in the autosomal gene encoding aquaporin-2. Expressed in Xenopus oocytes, the AQP2 gene mutations found in NDl have been shown to reduce the stability of the encoded protein. This study investigated the in vivo stability of mutant and wild-type aquaporin-2 proteins by measuring their excretion in urine of NDl patients and healthy individuals. On immunoblots, the urine samples from healthy volunteers revealed clear aquaporin-1 and aquaporin-2 signals in antidiuretic but not diuretic states. In the urine of a female patient, whose NDl is explained by low expression of the wild-type V2-receptor gene, aquaporin-2 excretion was high and comparable with that in a healthy individual during antidiuresis. In the urine of a male patient with a non-sense mutation in the V2-receptor gene, a weak aquaporin-2 signal was detected. In NDl patients with mutations in the aquaporin-2 gene, aquaporin-2 could not be detected in urine, suggesting a low stability of mutant aquaporin-2 proteins. In four out of seven NDl patients, aquaporin-1 excretion was relatively high, which suggests a compensatory increase in proximal reabsorption in NDl.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8793791     DOI: 10.1681/ASN.V76836

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  16 in total

1.  Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method.

Authors:  Sei Sasaki; Yasukazu Ohmoto; Toyoki Mori; Fusako Iwata; Masahiro Muraguchi
Journal:  Clin Exp Nephrol       Date:  2011-12-10       Impact factor: 2.801

2.  An impaired routing of wild-type aquaporin-2 after tetramerization with an aquaporin-2 mutant explains dominant nephrogenic diabetes insipidus.

Authors:  E J Kamsteeg; T A Wormhoudt; J P Rijss; C H van Os; P M Deen
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

3.  Urinary aquaporin-2 excretion during early human development.

Authors:  Marina Zelenina; Yanhong Li; Isabelle Glorieux; Catherine Arnaud; Christelle Cristini; Stéphane Decramer; Anita Aperia; Charlotte Casper
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

4.  Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries.

Authors:  Marianna Lo Pizzo; Gabriella Schiera; Italia Di Liegro; Carlo Maria Di Liegro; József Pál; Endre Czeiter; Endre Sulyok; Tamás Dóczi
Journal:  Neurol Sci       Date:  2012-11-10       Impact factor: 3.307

5.  Urinary aquaporin-2 in children with acute pyelonephritis.

Authors:  Elena A Rodionova; Alla A Kuznetsova; Elena I Shakhmatova; Natalia Prutskova; Søren Nielsen; Ulla Holtbäck; Yuri Natochin; Marina Zelenina
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

Review 6.  Vasopressin and the regulation of aquaporin-2.

Authors:  Justin L L Wilson; Carlos A Miranda; Mark A Knepper
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

7.  LIP5 interacts with aquaporin 2 and facilitates its lysosomal degradation.

Authors:  Bas W M van Balkom; Michelle Boone; Giel Hendriks; Erik-Jan Kamsteeg; Joris H Robben; H Christiaan Stronks; Anne van der Voorde; Francois van Herp; Peter van der Sluijs; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 10.121

8.  Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors.

Authors:  Scott S P Wildman; Michelle Boone; Claire M Peppiatt-Wildman; Alberto Contreras-Sanz; Brian F King; David G Shirley; Peter M T Deen; Robert J Unwin
Journal:  J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 10.121

9.  An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex.

Authors:  S M Mulders; D G Bichet; J P Rijss; E J Kamsteeg; M F Arthus; M Lonergan; M Fujiwara; K Morgan; R Leijendekker; P van der Sluijs; C H van Os; P M Deen
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Identification of Nipsnap1 as a novel auxiliary protein inhibiting TRPV6 activity.

Authors:  Joost P H Schoeber; Catalin N Topala; Kyu Pil Lee; Tim T Lambers; Guénola Ricard; Annemiete W C M van der Kemp; Martijn A Huynen; Joost G J Hoenderop; René J M Bindels
Journal:  Pflugers Arch       Date:  2008-04-08       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.